1
Hepatitis B Foundation, Doylestown, PA, USA; Baruch S Blumberg Institute, Doylestown, PA, USA. Electronic address: tim.block@bblumberg.org.
2
Clinical Center, National Institutes of Health, Bethesda, MD, USA.
3
Hepatitis B Foundation, Doylestown, PA, USA; Baruch S Blumberg Institute, Doylestown, PA, USA.
4
Hepatitis B Foundation, Doylestown, PA, USA.
5
U. California San Francisco School of Medicine and U. California at Berkeley School of Public Health, National Viral Hepatitis Roundtable, USA.
6
University of Pennsylvania School of Medicine and the Philadelphia Veterans Hospital, Philadelphia, PA, USA.
7
National Taiwan University, Taipei, Taiwan.
8
Baylor University College of Medicine, Dallas, TX, USA.
9
Toronto General Hospital, Toronto, Canada.
10
Hepatitis B Foundation, Doylestown, PA, USA; Stanford University Medical Center and Hospital, Palo Alto, CA, USA.
11
Stanford University School of Medicine, Palo Alto, CA, USA.
12
National Cancer Institute, NIH, Bethesda, MD, USA.
13
Mt. Sinai School of Medicine, New York, NY, USA.
14
Swedish Medical Center, Seattle, WA, USA.
15
National Institute of Biological Sciences, Beijing, China.
16
University of Michigan School of Medicine, Ann Arbor, MI, USA.
17
Alaska Native Medical Center, Anchorage, AK, USA.
18
Medical University of South Carolina, Charleston, SC, USA.
19
Baylor University Medical Center, Dallas, TX, USA.
20
Rockefeller University, New York, NY, USA.
21
Emory University, Atlanta, GA, USA.
22
Johns Hopkins University, Baltimore, MD, USA.
Abstract
In early 2017, the Hepatitis B Foundation invited 30 experts in the fields of hepatitis B and liver cancer research to identify projects they deemed important to the goal of finding a cure for chronic hepatitis B and D and the diseases with which these viral infections are associated. They were also asked to identify general categories of research and to prioritize sub-project topics within those areas. The experts generally agreed on broadly defined areas of research, but there was usually little difference between the highest and lowest scoring projects; for the most part, all programs described in this document were considered valuable and necessary. An executive summary of this discussion was recently published (Alter et al., Hepatology 2017). The present manuscript reports the areas of research identified by the workshop participants, provides a brief rationale for their selection, and attempts to express differences among the priorities assigned to each area of research, when such distinctions were expressed.